Market Research Reports

Hemoglobin A1c Testing Devices Market (End-use - Laboratory and Point-of-Care Testing Devices; Technologies - Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

94pages
Published Date: 2014-04-30
 

Description


This study covers the market analysis for various technologies and end-uses of hemoglobin A1c (HbA1c) testing devices. The stakeholders for this report include manufacturers of hemoglobin A1C testing analyzers and research organizations involved in developing new and innovative technologies for hemoglobin A1c testing.

The market overview section of this report gives a detailed description about the market dynamics and trends including drivers, restraints and opportunities that influence the current and future scenario of this market. This section also covers market attractiveness analysis and Porter’s five forces analysis to give an understanding about the competitive scenario of global hemoglobin A1C testing devices market. 

The global hemoglobin A1c testing devices market is analyzed on the basis of technologies and end-uses hemoglobin A1c testing. With respect to technologies, this study considers five testing categories, namely, immunoassays, ion-exchange high performance liquid chromatography (HPLC), direct enzymatic assay, boronate affinity chromatography and others (micro-optical detection method and capillary electrophoresis). Based on the end-uses, this market is categorized into laboratory testing and point-of-care (POC) testing segments. The above segments are analyzed on the basis of their market size (revenue) for the period 2011 to 2019 in terms of USD million, along with their growth forecast in terms of CAGR (%) for the period 2013 to 2019, considering 2012 as the base year. 

With respect to geographical distribution, the global hemoglobin A1C testing devices market has been classified into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). This section of report provides market size (for the period 2011 - 2019) and forecast (for the period 2013 - 2019) for each regional market in terms of USD million. The report further provides strategic recommendations, which would be helpful for the current market players and the new entrants to grow in the hemoglobin A1c testing devices market. 

This report concludes with the company profiles section which includes key information about major market players. Some of the major companies profiled in this report include Abbott Laboratories, Alere, Inc., Arkray, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., A. Menarini Diagnostics, F. Hoffmann-La Roche Ltd. and Siemens Healthcare.

The global hemoglobin A1c testing devices market is categorized into the following segments:

Hemoglobin A1cTesting Devices Market, by End-use
  • Laboratory Testing Devices
  • Point-of-Care (POC)Testing Devices
Hemoglobin A1cTesting Devices Market, by Technology
  • Ion-Exchange High Performance Liquid Chromatography (HPLC)
  • Immunoassay
  • Boronate Affinity Chromatography
  • Direct Enzymatic Assay 
  • Others (Micro-Optical Detection Method and Capillary Electrophoresis)
Hemoglobin A1cTesting Devices Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents


Table of Contents

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.4 Research Methodology
1.5 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Hemoglobin A1c Testing Devices Market
2.2 Comparative Analysis: Global Hemoglobin A1c Testing Devices Market, by Geography, 2012 & 2019 (Value %)

Chapter 3 Global Hemoglobin A1c Testing Devices Market Overview
3.1 Introduction and Market Definition
3.2 Market Drivers
      3.2.1 Rising Diabetic Patient Population
      3.2.2 Aging Population
      3.2.3 Proven Benefits of HbA1c Testing Leading to Rapid Adoption
3.3 Market Restraints
      3.3.1 Higher Test Cost
      3.3.2 Presence of Viable Substitutes
3.4 Market Opportunities
      3.4.1 Lucrative Market Opportunities in Emerging Economies
      3.4.2 Rapid Commercialization of Devices for Diagnosis of Diabetes
3.5 Porter’s Five Forces Analysis for the Global Hemoglobin A1c Testing Devices Market
      3.5.1 Bargaining Power of Suppliers
      3.5.2 Bargaining Power of Buyers
      3.5.3 Threat of New Entrants
      3.5.4 Threat of Substitutes
      3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Hemoglobin A1c Testing Devices Market, by Geography
3.7 Competitive Landscape
      3.7.1 Heat Map Analysis: Global Hemoglobin A1c Testing Devices Market, by Key Players

Chapter 4 Global Hemoglobin A1c Testing Devices Market, by End-Use
4.1 Overview
      4.1.1 Global Hemoglobin A1c Testing Devices Market Revenue, by End-Use, 2011 – 2019 (USD Million)
4.2 Comparative Analysis: Global Hemoglobin A1c Testing Devices Market, by End-Use, 2012 & 2019 (Value %)
4.3 Laboratory Testing Devices
      4.3.1 HbA1c Laboratory Testing Devices Market Revenue, 2011 – 2019 (USD Million)
4.4 Point-of-Care (POC) Testing Devices
      4.4.1 HbA1c Point-of-Care Testing Devices Market Revenue, 2011 – 2019 (USD Million)

Chapter 5 Global Hemoglobin A1c Testing Devices Market, by Technology
5.1 Overview
      5.1.1 Global Hemoglobin A1c Testing Devices Market Revenue, by Technology, 2011 – 2019 (USD Million)
5.2 Comparative Analysis: Global Hemoglobin A1c Testing Devices Market, by Technology, 2012 & 2019 (Value %)
5.3 Ion-Exchange High Performance Liquid Chromatography (HPLC)
      5.3.1 HbA1c Ion-Exchange HPLC Testing Devices Market Revenue, 2011 – 2019 (USD Million)
5.4 Immunoassay
      5.4.1 HbA1c Immunoassay Testing Devices Market Revenue, 2011 – 2019 (USD Million)
5.5 Boronate Affinity Chromatography
      5.5.1 HbA1c Boronate Affinity Chromatography Testing Devices Market Revenue, 2011 – 2019 (USD Million)
5.6 Direct Enzymatic Assay
      5.6.1 HbA1c Direct Enzymatic Assay Testing Devices Market Revenue, 2011 – 2019 (USD Million)
5.7 Others
      5.7.1 Other HbA1c Testing Devices Technologies Market Revenue, 2011 – 2019 (USD Million)

Chapter 6 Global Hemoglobin A1c Testing Devices Market, by Geography
6.1 Overview
      6.1.1 Global Hemoglobin A1c Testing Devices Market Revenue, by Geography, 2011 – 2019 (USD Million)
6.2 North America
      6.2.1 North America HbA1c Testing Devices Market Revenue, 2011 – 2019 (USD Million)
6.3 Europe
      6.3.1 Europe HbA1c Testing Devices Market Revenue, 2011 – 2019 (USD Million)
6.4 Asia-Pacific
      6.4.1 Asia-Pacific HbA1c Testing Devices Market Revenue, 2011 – 2019 (USD Million)
6.5 Rest of the World (RoW)
      6.5.1 Rest of the World HbA1c Testing Devices Market Revenue, 2011 – 2019 (USD Million)

Chapter 7 Recommendations
7.1 Improving Measurement of HbA1c
7.2 Investing in Emerging Economies
7.3 Developing Clinical Laboratory Improvement Amendments (CLIA) Waived Tests

Chapter 8 Company Profiles
8.1 Abbott Laboratories
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 Alere, Inc.
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Business Strategies
      8.2.5 Recent Developments
8.3 ARKRAY, Inc.
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Business Strategies
      8.3.5 Recent Developments
8.4 Bio-Rad Laboratories, Inc.
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Product Portfolio
      8.4.4 Business Strategies
      8.4.5 Recent Developments
8.5 Chek Diagnostics (Polymer Technology Systems, Inc.)
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Product Portfolio
      8.5.4 Business Strategies
      8.5.5 Recent Developments
8.6 Danaher Corporation (Beckman Coulter)
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Product Portfolio
      8.6.4 Business Strategies
      8.6.5 Recent Developments
8.7 EKF Diagnostics Holdings plc
      8.7.1 Company Overview
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Business Strategies
      8.7.5 Recent Developments
8.8 F. Hoffmann-La Roche Ltd.
      8.8.1 Company Overview
      8.8.2 Financial Overview
      8.8.3 Product Portfolio
      8.8.4 Business Strategies
      8.8.5 Recent Developments
8.9 Menarini Group
      8.9.1 Company Overview
      8.9.2 Financial Overview
      8.9.3 Product Portfolio
      8.9.4 Business Strategies
      8.9.5 Recent Developments
8.10 Sebia
      8.10.1 Company Overview
      8.10.2 Financial Overview
      8.10.3 Product Portfolio
      8.10.4 Business Strategies
      8.10.5 Recent Developments
8.11 Siemens Healthcare
      8.11.1 Company Overview
      8.11.2 Financial Overview
      8.11.3 Product Portfolio
      8.11.4 Business Strategies
      8.11.5 Recent Developments
8.12 Tosoh Corporation
      8.12.1 Company Overview
      8.12.2 Financial Overview
      8.12.3 Product Portfolio
      8.12.4 Business Strategies
      8.12.5 Recent Developments
8.13 Trinity Biotech plc
      8.13.1 Company Overview
      8.13.2 Financial Overview
      8.13.3 Product Portfolio
      8.13.4 Business Strategies
      8.13.5 Recent Developments

List of Figures

FIG. 1 Hemoglobin A1c Testing Devices Market Segmentation
FIG. 2 Global Hemoglobin A1c Testing Devices Market, by End-Use and Technologies, 2012 (USD Million)
FIG. 3 Comparative Analysis: Global Hemoglobin A1c Testing Devices Market, by Geography, 2012 & 2019 (Value %)
FIG. 4 Global Population, by Age-Group, 2000 & 2050 (%)
FIG. 5 Porter’s Five Forces Analysis for the Global Hemoglobin A1c Testing Devices Market
FIG. 6 Market Attractiveness Analysis of the Global Hemoglobin A1c Testing Devices Market, by Geography
FIG. 7 Heat Map Analysis: Global Hemoglobin A1c Testing Devices Market, by Key Players
FIG. 8 Comparative Analysis: Global Hemoglobin A1c Testing Devices Market, by End-Use, 2012 & 2019 (Value %)
FIG. 9 HbA1c Laboratory Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 10 HbA1c Point-of-Care Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Comparative Analysis: Global Hemoglobin A1c Testing Devices Market, by Technology, 2012 & 2019 (Value %)
FIG. 12 HbA1c Ion-Exchange HPLC Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 HbA1c Immunoassay Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 HbA1c Boronate Affinity Chromatography Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 HbA1c Direct Enzymatic Assay Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Other HbA1c Testing Device Technologies Market Revenue, 2011 – 2019 (USD Million)
FIG. 17 North America HbA1c Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 Europe HbA1c Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 19 Asia-Pacific HbA1c Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 20 Rest of the World HbA1c Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 21 Abbott Laboratories (Immunochemistry Segment): Annual Revenue, 2010 – 2012 (USD Million)
FIG. 22 Alere, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 23 Bio-Rad Laboratories, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 24 Danaher Corporation: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 25 EKF Diagnostics Holdings plc: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 26 F. Hoffmann-La Roche Ltd. (Diagnostics Business): Annual Revenue, 2010 – 2012 (USD Million)
FIG. 27 Menarini Group: Consolidated Turnover, 2010 – 2012 (USD Million)
FIG. 28 Sebia: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 29 Siemens Healthcare: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 30 Tosoh Corporation: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 31 Trinity Biotech plc: Annual Revenue, 2010 – 2012 (USD Million)

List of Tables

TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Hemoglobin A1c Testing Devices Market
TABLE 3 Comparing DCCT-HbA1c and IFCC-HbA1c Results
TABLE 4 Worldwide Diabetic Population, by Region, 2013 & 2035 (Million Individuals)
TABLE 5 Top 10 Countries/Territories by Diabetes Prevalence (20 years to 79 years), 2013 & 2035
TABLE 6 Global Hemoglobin A1c Testing Devices Market Revenue, by End-Use, 2011 – 2019 (USD Million)
TABLE 7 Global Hemoglobin A1c Testing Devices Market Revenue, by Technology, 2011 – 2019 (USD Million)
TABLE 8 Global Hemoglobin A1c Testing Devices Market Revenue, by Geography, 2011 – 2019 (USD Million)
TABLE 9 Top 5 European Countries, by Number of Diabetes Cases, 2012 (Million)

Enquiry Before Buying


Free Market Analysis


Testing the levels of glycated hemoglobin provides an assurance to the healthcare practitioner about the patient’s blood glucose level. This test can be used for diagnosis and monitoring of hemoglobin A1c levels in diabetic patients. Since A1C test reflects the average amount of glucose for the past 2 to 3 months, it is opined to be more reliable than conventional blood glucose test. Physicians are increasingly prescribing HbA1c test to their patients which will lead to an increase in the test volume. Moreover, rising diabetes incidence rate is a major driver for the HbA1c testing market. With growing awareness about prevention and management of diabetes, the demand for HbA1c testing devices will rise rapidly especially in the Asia-Pacific, Latin America, MiddleEast and African regions.

Moreover, advent of these devices for the diagnosis of diabetes will further bolster the demand for these devices in future. For instance, approval for the COBAS INTEGRA 800 Tina-quant HbA1cDx assay, in 2013and Abbott’s ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test approved in 2014 for the diagnosis of diabetes were the major steps in the hemoglobin A1c testing industry. With this diagnostic tools, physicians can combat the rising incidence of diabetes with timely and appropriate actions in identifying and managing diabetes.

Based on the end-use, the global hemoglobin A1c testing devices market is categorized into two segments namely laboratory testing and point-of-care (POC) testing devices. Laboratory testing devices held the majority share of the market in 2012, while the global market for point-of-care testing devices is expected to grow at a faster paceduring the forecast period.

Based on technologies, the hemoglobin A1c testing devices market is further categorized into five segments, namely, ion-exchange HPLC, immunoassay, boronate affinity chromatography, direct enzymatic assay and others. The boronate affinity chromatography market will be growing at a faster pace during the forecast period as this technology has no interference from hemoglobin variants and is also used in both laboratory as well as point-of-care testing. Healthcare practitioners are recommending the use of devices which offer least variant interference and this would elevate the demand for boronate affinity chromatography in HbA1c testing.

Geographically, the global hemoglobin A1c testing devices market is categorized into four regions, North America, Europe, Asia-Pacific and Rest of the World (RoW). North America was the market leader in 2012 due to high patient awareness coupled with the presence of sophisticated healthcare infrastructure. Also, the adoption of automated processes is rapid in this region which results in high demand for advanced laboratory and point-of-care testing devices with new technologies. Conversely, the Asia-Pacific region is expected to grow at a higher CAGR than others, owing to the presence of unmet healthcare needs, large diabetic population and increase in healthcare expenditure. Moreover, rising diabetes awareness among the general population will generate demand for diagnostic devices for HbA1c testing. Also, inadequate accessibility to the clinical laboratories in this region, demands more of point-of-care devices to enable immediate results during the patient visit.

The global hemoglobin A1c testing devices market is characterized by the presence of some of the major companies including Abbott Laboratories, Alere, Inc., Arkray, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare and Trinity Biotech plc. These players are seeking to develop HbA1c analyzers with quicker turnaround time, higher accuracy and reliable results. Moreover, approval of devices for diagnosis of diabetes has reinforced the development activities of these organizations to introduce products for rapid and early diagnosis. 

global-hemoglobin-a1c-testing-devices-market-revenue-by-technology-2012
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research